News > Latest Health and Medical news

Today's Health & Medical News


GluvSnap on Facebook


Health News Videos

Cleviprex Recalled due to Particulates
Angie Christensen: Forensic Anthropologist.mp4
Vivian Morales: Medical Technologist.mp4
Peter Bandettini: Biophysicist.mp4
Keisha Hines-Harris: Biological Technician.mp4
Wes Studi: Don't Get Dont Spread
Wes Studi: Signs
Wes Studi: Antivirals
Start at the Store: Prevent Foodborne Illness (Consumer Update)
Inicio en la Tienda: Prevenga las Enfermedades de Transmisión Alimentaria (C...
Synex II Spinal Implant Recalled
Ear Candling: Ineffective and Risky
Preventing Cross-Contamination in Endoscope Processing
New Warnings on Norpramin
Chondrolysis with Continuously Infused Local Anesthetics


Hereditary Condition Causing Limb Weakness Traced to Gene for Menkes disease - a Rare Disorder
Mar 12th of 2010 Diseases Genetics Musculoskeletal FEATURED

From Genetics Health Center
A gene that causes a fatal childhood brain disorder can also cause adults to develop peripheral neuropathy, a condition resulting in weakness and decreased sensation in the hands and limbs, according to a study by researchers at the National Institutes of Health and other institutions. The study is the first to show that different mutations in the same gene cause the two seemingly unrelated disorders.
Read more       Comments

Food Allergy-Related Disorder Linked to Master Allergy Gene
Mar 8th of 2010 Research Immunology

From Immunology Health Center
Scientists have identified a region of a human chromosome that is associated with eosinophilic esophagitis (EoE), a recently recognized allergic disease. People with EoE frequently have difficulty eating or may be allergic to one or more foods. This study further suggests that a suspected so-called master allergy gene may play a role in the development of this rare but debilitating disorder.
Read more       Comments
FDA Announces Possible Safety Concern for HIV Drug Combination
Mar 1st of 2010 Diseases HIV/AIDS Immunology

From HIV/AIDS Health Center
The U.S. Food and Drug Administration today announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart.
Read more       Comments

Information on Life after Cancer Now Available on NIHSeniorHealth.gov
Mar 1st of 2010 Other News Seniors & Aging Cancer FEATURED

From Seniors & Aging Health Center
Older adults who have survived cancer can find out what to expect once treatment ends in Life after Cancer, the newest topic on NIHSenior Health. Visitors to the site will learn about managing follow-up care, physical and emotional changes, and relationships with family and friends. The topic also addresses how a person's age and health status can affect recovery and survival. This is important information for older adults who make up about 60 percent of cancer survivors and whose cancer tre...
Read more       Comments

NIH Clinical Trial Comparing Two Stroke Prevention Procedures Shows Surgery and Stenting Equally Safe and Effective
Mar 1st of 2010 Research Stroke FEATURED

From Stroke Health Center
A major new study of people at risk for stroke showed that two medical procedures designed to prevent future strokes are safe and effective overall. Physicians will now have more options in tailoring treatments for their patients at risk for stroke. In the trial of 2,502 participants, carotid endarterectomy (CEA), a surgical procedure to clear blocked blood flow and considered the gold standard prevention treatment, was compared to carotid artery stenting (CAS), a newer and less invasive proc...
Read more       Comments

NHGRI Launches Online Genomics Center for Educators of Nurses, Physician Assistants
Mar 1st of 2010 Student affairs
An online tool to help educators teach the next generation of nurses and physician assistants about genetics and genomics was launched today by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health. The tool is part of NHGRI's effort to address the growing need among health care professionals for knowledge in this area, which is paving the way for more individualized approaches to detect, treat and prevent many diseases.
Read more       Comments

Abnormal Glycoprotein Antibodies Identified as Possible Biomarkers for Cancer
Feb 22nd of 2010 Diseases Cancer FEATURED

From Cancer Health Center
Scientists have found that cancer patients produce antibodies that target abnormal glycoproteins (proteins with sugar molecules attached) made by their tumors. The result of this work suggests that antitumor antibodies in the blood may provide a fruitful source of sensitive biomarkers for cancer detection. The study, supported in part by the National Cancer Institute (NCI), part of the National Institutes of Health, appears in the Feb. 15, 2010 issue of the journal Cancer Research.
Read more       Comments

Scientists Map Genetic Regulatory Elements for the Heart
Feb 22nd of 2010 Research Genetics Cardiovascular

From Genetics Health Center
Scientists have devised a new computational model that can be used to reveal genetic regulatory elements responsible for development of the human heart and maintenance of its function. Although the teams focused on the heart, the computational method they developed is broadly applicable to other tissues, and was successfully used to identify regulatory elements for cells of the limbs and brain. Cataloging these regulatory sequences may improve understanding of diseases and lays the groundwor...
Read more       Comments

FDA Approves Rituxan (Rituximab) to Treat Chronic Lymphocytic Leukemia
Feb 18th of 2010 Drugs Cancer Blood & Lymphatic

From Cancer Health Center
The U.S. Food and Drug Administration today approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a slowly progressing blood and bone marrow cancer. Rituxan, an anti-cancer drug, is intended for patients with CLL who are beginning chemotherapy for the first time and for those who have not responded to other cancer drugs for CLL. Rituxan is administered with two other chemotherapy drugs, fludarabine and cyclophosphamide.
Read more       Comments

Scientists Identify Maternal and Fetal Genes That Increase Preterm Birth Risk
Feb 16th of 2010 Research Pregnancy Genetics

From Pregnancy Health Center
Researchers at the National Institutes of Health have identified DNA variants in mothers and fetuses that appear to increase the risk for preterm labor and delivery. The DNA variants were in genes involved in the regulation of inflammation and of the extracellular matrix, the mesh-like material that holds cells within tissues.
Read more       Comments





Copyright 2009-2010 Emma Concepts International, Inc. All rights reserved. | Terms of Service | Privacy Policy | Advertise
GluvSnap.com’s content is for educational purposes only and this page and other pages on GluvSnap do not contain medical advice. The information on this website is not a substitute for professional medical advice. Users further agree to abide by the terms of service. Trademarks are properties of their respective owners.